Effects of narcotic drugs (dexmedetomidine) or preoperative functional exercise on postoperative gastrointestinal function recovery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100052392

Enrollment

Unknown

Registered

2021-10-24

Start date

2021-10-31

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia and postoperative gastrointestinal function

Interventions

Dexmedetomidine group:Dexmedetomidine

Preoperative functional exercise group:Preoperative functional exercise

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ASA grade I-II, 18-80 years old, body mass index (BMI) 20-30 kg/m2 with normal cognitive function.

Exclusion criteria

Exclusion criteria: History of allergy to narcotic drugs; COVID - 19; Cerebral hemorrhage or stroke; Dysfunction of important organs such as heart, brain and kidney; The patient had abnormal gastrointestinal function before surgery. Preoperative long-term use of drugs to promote gastrointestinal function; Preoperative complicated with massive gastrointestinal bleeding;The baseline rate was less than 50 beats/min for bradyarrhythmias; Patients or family members refuse.

Design outcomes

Primary

Measure	Time frame
the time to first flatus;	—

Secondary

Measure	Time frame
Postoperative gastrointestinal function;Pain score;sleep quality;Postoperative nausea and vomiting;Incidence of delirium;	—

Countries

China

Contacts

Public ContactWu Yu

Bethune International Peace Hospital

vwuyuv@163.com+86 18633487638

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026